Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Discover Oncology
Published in:

Open Access 01-12-2024 | Review

MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies

Authors: Jinxing Wei, Xianghui Wang, Duo Yu, Yanyang Tu, Yaoyu Yu

Published in: Discover Oncology | Issue 1/2024

Login to get access

Abstract

This paper provides an exhaustive overview of the intricate interplay between microRNAs (miRNAs) and autophagy in the context of human cancers, underscoring the pivotal role these non-coding RNAs play in modulating autophagic pathways and their implications for cancer development, progression, and resistance to therapy. MiRNAs, as critical regulators of gene expression post-transcription, influence various biological processes, including autophagy, a catabolic mechanism essential for cellular homeostasis, stress response, and survival. The review meticulously delineates the mechanisms through which miRNAs impact autophagy by targeting specific genes and signaling pathways, thereby affecting cancer cell proliferation, metastasis, and response to chemotherapy. It highlights several miRNAs with dual roles, acting either as oncogenes or tumor suppressors based on the cellular context and the specific autophagic pathways they regulate. The paper further explores the therapeutic potential of targeting miRNA-autophagy axis, offering insights into novel strategies for cancer treatment through modulation of this axis. Emphasizing the complexity of the miRNA-autophagy relationship, the review calls for more in-depth studies to unravel the nuanced regulatory networks between miRNAs and autophagy in cancer, which could pave the way for the development of innovative therapeutic interventions and diagnostic tools.
Literature
1.
2.
Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6(5):376–85.PubMedCrossRef
3.
4.
5.
6.
7.
Lee Y, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425(6956):415–9.PubMedCrossRef
8.
9.
Zhang W, et al. miR-33b in human cancer: mechanistic and clinical perspectives. Biomed Pharmacother. 2023;161: 114432.PubMedCrossRef
10.
Li Z, et al. The miR-302/367 cluster: aging, inflammation, and cancer. Cell Biochem Funct. 2023;41(7):752–66.PubMedCrossRef
11.
Bi W, et al. The diagnostic and prognostic role of miR-27a in cancer. Pathol Res Pract. 2023;247: 154544.PubMedCrossRef
12.
Sukmana BI, et al. A thorough and current study of miR-214-related targets in cancer. Pathol Res Pract. 2023;249: 154770.PubMedCrossRef
13.
Li J, et al. Role of miR-21 in the diagnosis of colorectal cancer: meta-analysis and bioinformatics. Pathol Res Pract. 2023;248: 154670.PubMedCrossRef
14.
Ashrafizadeh M, et al. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: role of microRNAs and upstream mediators. Cell Signal. 2021;78: 109871.PubMedCrossRef
15.
16.
Wienholds E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005;309(5732):310–1.PubMedCrossRef
17.
18.
19.
Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143(3):550–63.PubMedCrossRef
20.
Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279–94.PubMedCrossRef
21.
22.
23.
Qin N, et al. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype. Theranostics. 2020;10(24):11264–77.PubMedPubMedCentralCrossRef
24.
Rezaei T, et al. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis. Eur J Pharmacol. 2020;888: 173483.PubMedCrossRef
25.
Dastmalchi N, et al. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sci. 2020;259: 118239.PubMedCrossRef
26.
Aslan C, et al. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs. Life Sci. 2020;258: 118094.PubMedCrossRef
27.
Alizadeh M, et al. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy. J Cell Physiol. 2019;234(11):19280–97.PubMedCrossRef
28.
Xu B, et al. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells. NeuroReport. 2020;31(6):498–506.PubMedCrossRef
29.
Gao A-M, et al. circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression. Cell Signal. 2020;72: 109622.PubMedCrossRef
30.
Hu T, et al. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells. J Cell Physiol. 2020;235(11):8319–33.PubMedCrossRef
31.
32.
Meng Q, et al. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967.PubMedPubMedCentralCrossRef
33.
Huang L, et al. MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2. Pharmacol Res. 2020;156: 104774.PubMedCrossRef
34.
35.
Khandia R, et al. A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells. 2019;8(7):674.PubMedPubMedCentralCrossRef
36.
37.
38.
Yao R-Q, et al. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021;17(2):385–401.PubMedCrossRef
39.
40.
41.
Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–64.PubMedCrossRef
42.
43.
Liang S, et al. microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer. Biomed Pharmacother. 2020;132: 110799.PubMedCrossRef
44.
Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013;14(12):759–74.PubMedCrossRef
45.
Tian Y, et al. Crosstalk between 5-methylcytosine and N(6)-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Mol Cancer. 2023;22(1):5.PubMedPubMedCentralCrossRef
46.
47.
48.
Hosokawa N, et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–91.PubMedPubMedCentralCrossRef
49.
50.
Tripathi DN, et al. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2–mediated suppression of mTORC1. Proc Natl Acad Sci. 2013;110(32):E2950–7.PubMedPubMedCentralCrossRef
51.
52.
Karanasios E, et al. Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J Cell Sci. 2013;126(22):5224–38.PubMed
53.
54.
55.
Matsumoto G, et al. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet. 2015;24(15):4429–42.PubMedCrossRef
56.
Richter B, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci. 2016;113(15):4039–44.PubMedPubMedCentralCrossRef
57.
Meléndez A, et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science. 2003;301(5638):1387–91.PubMedCrossRef
58.
Axe EL, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701.PubMedPubMedCentralCrossRef
59.
Dooley HC, et al. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12–5-16L1. Mol Cell. 2014;55(2):238–52.PubMedPubMedCentralCrossRef
60.
Polson HE, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy. 2010;6(4):506–22.PubMedCrossRef
61.
62.
63.
Birgisdottir ÅB, Lamark T, Johansen T. The LIR motif–crucial for selective autophagy. J Cell Sci. 2013;126(15):3237–47.PubMedCrossRef
64.
Ktistakis NT, Tooze SA. Digesting the expanding mechanisms of autophagy. Trends Cell Biol. 2016;26(8):624–35.PubMedCrossRef
65.
Carlsson SR, Simonsen A. Membrane dynamics in autophagosome biogenesis. J Cell Sci. 2015;128(2):193–205.PubMed
66.
67.
68.
69.
Shibutani ST, Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014;24(1):58–68.PubMedCrossRef
70.
Tsuboyama K, et al. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. Science. 2016;354(6315):1036–41.PubMedCrossRef
71.
72.
Nakamura S, Yoshimori T. New insights into autophagosome–lysosome fusion. J Cell Sci. 2017;130(7):1209–16.PubMedCrossRef
73.
De Leo MG, et al. Autophagosome–lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL. Nat Cell Biol. 2016;18(8):839–50.PubMedPubMedCentralCrossRef
74.
75.
76.
77.
78.
79.
80.
Piya S, et al. Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia. Blood J Am Soc Hematol. 2016;128(9):1260–9.
81.
Chittaranjan S, et al. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and-resistant triple-negative breast cancer. Clin Cancer Res. 2014;20(12):3159–73.PubMedCrossRef
82.
83.
84.
YiRen H, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174.PubMedPubMedCentralCrossRef
85.
Yang MC, et al. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol Cancer. 2015;14:179.PubMedPubMedCentralCrossRef
86.
Xu WP, et al. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 2020;69(7):1309–21.PubMedCrossRef
87.
Ranieri R, et al. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux. Cell Death Differ. 2018;25(2):353–67.PubMedCrossRef
88.
Su Z, et al. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14:1–14.CrossRef
89.
Vera-Ramirez L. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy. in Seminars in Cancer Biology. 2020. Elsevier.
90.
Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene. 2017;36(12):1619–30.PubMedCrossRef
91.
Chen H-T, et al. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019;18(1):1–19.PubMedPubMedCentralCrossRef
92.
93.
Lazova R, et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res. 2012;18(2):370–9.PubMedCrossRef
94.
Görgülü K, et al. Levels of the autophagy-related 5 protein affect progression and metastasis of pancreatic tumors in mice. Gastroenterology. 2019;156(1):203–17.PubMedCrossRef
95.
Shen T, et al. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy. J Hematol Oncol. 2018;11:1–16.CrossRef
96.
97.
98.
99.
Jing Z, et al. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Cancer Lett. 2015;356(2 Part B):332–8.PubMedCrossRef
100.
101.
102.
Hosokawa N, et al. Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy. 2009;5(7):973–9.PubMedCrossRef
103.
104.
Wu H, et al. MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts. Cell Signal. 2012;24(11):2179–86.PubMedCrossRef
105.
Wang Z, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014;5(16):7013.PubMedPubMedCentralCrossRef
106.
Huang Y, Chuang AY, Ratovitski EA. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle. 2011;10(22):3938–47.PubMedPubMedCentralCrossRef
107.
108.
Korkmaz G, et al. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy. 2012;8(2):165–76.PubMedCrossRef
109.
110.
Chatterjee A, Chattopadhyay D, Chakrabarti G. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression. PLoS ONE. 2014;9(4): e95716.PubMedPubMedCentralCrossRef
111.
Huang Y, Guerrero-Preston R, Ratovitski EA. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle. 2012;11(6):1247–59.PubMedPubMedCentralCrossRef
112.
Shi G, et al. Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia. 2013;61(4):504–12.PubMedCrossRef
113.
114.
Ravikumar B, et al. Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci. 2008;121(10):1649–60.PubMedCrossRef
115.
Chang Y, et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology. 2012;143(1):177–87.PubMedCrossRef
116.
Comincini S, et al. microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biol Ther. 2013;14(7):574–86.PubMedPubMedCentralCrossRef
117.
Mikhaylova O, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21(4):532–46.PubMedPubMedCentralCrossRef
118.
Lu C, et al. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology. 2014;146(1):188–99.PubMedCrossRef
119.
120.
Nguyen HTT, et al. Crohn’s disease–associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology. 2014;146(2):508–19.PubMedCrossRef
121.
122.
Kovaleva V, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Can Res. 2012;72(7):1763–72.CrossRef
123.
Yang J, et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age. 2013;35:11–22.PubMedCrossRef
124.
125.
126.
127.
Brest P, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet. 2011;43(3):242–5.PubMedCrossRef
128.
Roccaro AM, et al. microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia. Blood J Am Soc Hematol. 2010;116(9):1506–14.
129.
Yan D, et al. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. 2012.
130.
Li L, et al. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med. 2013;13:109–17.PubMedCrossRef
131.
Chio C-C, et al. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch Toxicol. 2013;87:459–68.PubMedCrossRef
132.
Tian L, et al. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. Med Oncol. 2014;31:1–10.CrossRef
133.
Wu Z, et al. Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett. 2012;586(16):2459–67.PubMedCrossRef
134.
Meenhuis A, et al. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1–regulated pathways in mice. Blood J Am Soc Hematol. 2011;118(4):916–25.
135.
136.
Ge Y-Y, et al. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R. Oncotarget. 2014;5(15):6218.PubMedPubMedCentralCrossRef
137.
Sui X, et al. Epigenetic modifications as regulatory elements of autophagy in cancer. Cancer Lett. 2015;360(2):106–13.PubMedCrossRef
138.
139.
Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol: WJG. 2014;20(24):7894.PubMedPubMedCentralCrossRef
140.
Kiga K, et al. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun. 2014;5(1):4497.PubMedCrossRef
141.
Seol HS, et al. Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. Cancer Lett. 2014;353(2):232–41.PubMedPubMedCentralCrossRef
142.
Zhang P-P, et al. DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells. J Biol Chem. 2014;289(35):24724–35.PubMedPubMedCentralCrossRef
143.
Gao W, et al. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene. 2015;34(13):1629–40.PubMedCrossRef
144.
Bi H-C, et al. N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. Carcinogenesis. 2014;35(10):2264–72.PubMedPubMedCentralCrossRef
145.
Zhang E-B, et al. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget. 2014;5(8):2276.PubMedPubMedCentralCrossRef
146.
Ng HY, et al. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and-34b/c in acute promyelocytic leukaemia. J Clin Pathol. 2014;67(7):626–31.PubMedCrossRef
147.
148.
Kita Y, et al. Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn. 2014;14(6):673–83.PubMedCrossRef
149.
Fu L-L, et al. MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol. 2012;44(5):733–6.PubMedCrossRef
150.
Tschan MP, et al. The autophagy gene ULK1 plays a role in AML differentiation and is negatively regulated by the oncogenic MicroRNA 106a. Blood. 2010;116(21):503.CrossRef
151.
152.
153.
154.
Wang S-Y, et al. Core signaling pathways of survival/death in autophagy-related cancer networks. Int J Biochem Cell Biol. 2011;43(9):1263–6.PubMedCrossRef
155.
Abraham D, et al. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res. 2011;17(14):4772–81.PubMedCrossRef
156.
Pavlides S, et al. The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle. 2010;9(17):3485–505.PubMedPubMedCentralCrossRef
157.
Gandellini P, et al. MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets. 2011;15(3):265–79.PubMedCrossRef
158.
159.
Liang XH, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–6.PubMedCrossRef
160.
Mariño G, et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem. 2007;282(25):18573–83.PubMedCrossRef
161.
Morselli E, et al. Anti-and pro-tumor functions of autophagy. Biochimica et Biophysica Acta BBA Molecular Cell Research. 2009;1793(9):1524–32.PubMedCrossRef
162.
Pourhanifeh MH, et al. Autophagy-related microRNAs: possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacol Res. 2020;161: 105133.PubMedCrossRef
163.
164.
Hesari A, et al. Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status. Int J Cancer. 2019;144(6):1215–26.PubMedCrossRef
165.
Shafabakhsh R, et al. Targeting regulatory T cells by curcumin: a potential for cancer immunotherapy. Pharmacol Res. 2019;147: 104353.PubMedCrossRef
166.
Tili E, et al. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem Pharmacol. 2010;80(12):2057–65.PubMedPubMedCentralCrossRef
167.
Davidson LA, et al. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis. 2009;30(12):2077–84.PubMedPubMedCentralCrossRef
168.
Mudduluru G, et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185–97.PubMedCrossRef
169.
Ashrafizadeh M, et al. (Nano) platforms in breast cancer therapy: drug/gene delivery, advanced nanocarriers and immunotherapy. Med Res Rev. 2023;43:2115.PubMedCrossRef
170.
Li B, Ashrafizadeh M, Jiao T. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis. Int J Biol Macromol. 2024;260: 129391.PubMedCrossRef
171.
Li T, et al. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives. Drug Discovery Today. 2024;29(1): 103851.PubMedCrossRef
172.
Ashrafizadeh M, et al. Chitosan-based nanoscale systems for doxorubicin delivery: exploring biomedical application in cancer therapy. Bioeng Transl Med. 2023;8(1): e10325.PubMedCrossRef
173.
Ashrafizadeh M, et al. (Nano) platforms in bladder cancer therapy: challenges and opportunities. Bioeng Transl Med. 2023;8(1): e10353.PubMedCrossRef
174.
Jing Z, et al. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Cancer Lett. 2015;356(2):332–8.PubMedCrossRef
175.
Liang GF, et al. PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett. 2011;6:1–9.CrossRef
176.
Cao M, et al. Protamine sulfate–nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells. Nanoscale. 2013;5(24):12120–5.PubMedCrossRef
177.
Zheng B, et al. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy. Nanomedicine. 2018;13(7):769–85.PubMedCrossRef
178.
Akkoc Y, Gozuacik D. MicroRNAs as major regulators of the autophagy pathway. Biochimica et Biophysica Acta BBA Molecular Cell Research. 2020;1867(5):118662.PubMedCrossRef
179.
Belalcazar A, et al. Inhibiting heat shock protein 90 and the ubiquitin-proteasome pathway impairs metabolic homeostasis and leads to cell death in human pancreatic cancer cells. Cancer. 2017;123(24):4924–33.PubMedCrossRef
180.
Raju GSR, et al. Targeting autophagy in gastrointestinal malignancy by using nanomaterials as drug delivery systems. Cancer Lett. 2018;419:222–32.PubMedCrossRef
181.
Chen L, et al. Chapter one—regulation of autophagy by MiRNAs and their emerging roles in tumorigenesis and cancer treatment. In: Galluzzi L, Vitale I, editors., et al., International review of cell and molecular biology. Academic Press; 2017. p. 1–26.
182.
183.
Ramalinga M, et al. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. Oncotarget. 2015;6(33):34446.PubMedPubMedCentralCrossRef
184.
Sun Q, et al. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int J Cancer. 2015;136(5):1003–12.PubMedCrossRef
185.
Li X, et al. miR-22 targets the 3′ UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumor Biol. 2014;35:6021–8.CrossRef
186.
Zhang H, et al. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Lett. 2015;356(2):781–90.PubMedCrossRef
187.
Yu X, et al. MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy. Mol Cancer. 2015;14(1):1–16.CrossRef
188.
189.
Zheng B, et al. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib. Biochem Biophys Res Commun. 2015;459(2):234–9.PubMedCrossRef
190.
Zou Z, et al. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem. 2012;287(6):4148–56.PubMedCrossRef
191.
He C, et al. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Oncotarget. 2015;6(30):28867.PubMedPubMedCentralCrossRef
192.
Peralta-Zaragoza O, et al. Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells. BMC Cancer. 2016;16:1–16.CrossRef
193.
Song L, et al. MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway. Tumor Biology. 2016;37:12161–8.PubMedCrossRef
194.
Tazawa H, et al. Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. Int J Cancer. 2012;131(12):2939–50.PubMedCrossRef
195.
196.
Wang ZC, et al. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5. Int J Biochem Cell Biol. 2019;111:63–71.PubMedCrossRef
197.
Zhao J, et al. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin. Gene. 2016;576(2 Pt 2):828–33.PubMedCrossRef
198.
Luo M, et al. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma. Cell Signal. 2018;42:30–43.PubMedCrossRef
199.
200.
Zhang W, et al. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy. Eur Rev Med Pharmacol Sci. 2019;23(6):2444–52.PubMed
201.
Li YL, et al. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy. Hum Cell. 2020;33(3):610–8.PubMedCrossRef
202.
Zhao P, et al. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles. Acta Biomater. 2018;72:248–55.PubMedCrossRef
203.
Yang S, et al. MicroRNA-375 targets ATG14 to inhibit autophagy and sensitize hepatocellular carcinoma cells to sorafenib. Onco Targets Ther. 2020;13:3557–70.PubMedPubMedCentralCrossRef
204.
205.
Tan S, et al. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol Med. 2016;37(4):1030–8.PubMedCrossRef
206.
Chatterjee A, Chattopadhyay D, Chakrabarti G. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cell Signal. 2015;27(2):189–203.PubMedCrossRef
207.
Li Y, et al. MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells. Oncol Lett. 2016;12(5):4203–8.PubMedPubMedCentralCrossRef
208.
Yu Y, et al. Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia. 2012;26(8):1752–60.PubMedCrossRef
209.
Du X, et al. miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy. Exp Ther Med. 2018;15(1):599–605.PubMed
210.
Xu R, et al. MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy. Oncol Rep. 2016;35(3):1757–63.PubMedCrossRef
211.
Yang X, et al. Intensified beclin-1 mediated by low expression of Mir-30a-5p promotes chemoresistance in human small cell lung cancer. Cell Physiol Biochem. 2017;43(3):1126–39.PubMedCrossRef
212.
Khalil NA, et al. MicroRNA 30a mediated autophagy and imatinib response in Egyptian chronic myeloid leukemia patients. Indian J Hematol Blood Transfus. 2020;36(3):491–7.PubMedCrossRef
213.
Pan B, et al. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget. 2015;6(1):317–31.PubMedCrossRef
214.
Hua L, Zhu G, Wei J. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Cell Biol Int. 2018;42(9):1240–9.PubMedCrossRef
215.
216.
217.
Huang H, et al. miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1. Int J Oncol. 2018;53(6):2769–79.PubMed
218.
Liao H, et al. Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer. Oncol Rep. 2016;35(1):64–72.PubMedCrossRef
219.
Hu Z, et al. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway. Cell Cycle. 2020;19(2):193–206.PubMedCrossRef
220.
221.
222.
223.
224.
Liu L, et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 2011;25(1):23–31.PubMedCrossRef
225.
226.
Ran X, et al. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy. Int J Clin Exp Pathol. 2015;8(6):6617–26.PubMedPubMedCentral
227.
Chen Y, et al. MiR-142-3p overexpression increases chemo-sensitivity of NSCLC by inhibiting HMGB1-mediated autophagy. Cell Physiol Biochem. 2017;41(4):1370–82.PubMedCrossRef
228.
Shi Y, et al. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. Braz J Med Biol Res. 2019;52(11): e8657.PubMedPubMedCentralCrossRef
229.
Yu Y, et al. miR- 26a sensitizes melanoma cells to dabrafenib via targeting HMGB1-dependent autophagy pathways. Drug Des Devel Ther. 2019;13:3717–26.PubMedPubMedCentralCrossRef
230.
231.
Chia WJ, Tang BL. Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta. 2009;1795(2):110–6.PubMed
232.
Li B, et al. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression. Cancer Lett. 2017;410:212–27.PubMedPubMedCentralCrossRef
233.
Jin F, et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Cell Death Dis. 2017;8(1): e2540.PubMedPubMedCentralCrossRef
234.
Rothschild SI, et al. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Lung Cancer. 2017;107:73–83.PubMedCrossRef
235.
236.
Fitzwalter BE, et al. Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover. Dev Cell. 2018;44(5):555-565.e3.PubMedPubMedCentralCrossRef
237.
Zhou Y, et al. miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells. Cell Death Dis. 2019;10(11):843.PubMedPubMedCentralCrossRef
238.
239.
Wu C, et al. Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol. 2016;48(6):2236–46.PubMedCrossRef
240.
Chen PH, et al. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chem Biol Interact. 2018;291:144–51.PubMedCrossRef
241.
Calin GA, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci. 2004;101(9):2999–3004.PubMedPubMedCentralCrossRef
242.
243.
244.
Gaur S, et al. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget. 2015;6(30):29161.PubMedPubMedCentralCrossRef
245.
246.
Jing Y, et al. Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biol Toxicol. 2020;36(6):517–36.PubMedCrossRef
247.
Ashrafizadeh M, et al. MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity. Eur J Pharmacol. 2021;892: 173660.PubMedCrossRef
248.
249.
Guk K, et al. Fluorescence amplified sensing platforms enabling miRNA detection by self-circulation of a molecular beacon circuit. Chem Commun (Camb). 2019;55(24):3457–60.PubMedCrossRef
250.
Metadata
Title
MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies
Authors
Jinxing Wei
Xianghui Wang
Duo Yu
Yanyang Tu
Yaoyu Yu
Publication date
01-12-2024
Publisher
Springer US
Published in
Discover Oncology / Issue 1/2024
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-024-01525-9

Other articles of this Issue 1/2024

Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials

Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis

Effect of early peri-operative arterial lactate concentration level ratios on post-hepatectomy liver failure

Monte Carlo dosimetry study of newly designed shielded applicators for intensity modulated brachytherapy of cervical and vaginal cancers

Association of residual ductal carcinoma in situ with breast cancer treatment outcomes after neoadjuvant chemotherapy according to hormone receptor status

Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits